Antimitotic effects of dehydroretronecine pyrrole.
D000818:Animals; D001798:Blood Proteins; D001835:Body Weight; D003967:Diarrhea / Q000139:chemically induced; D005753:Gastric Mucosa / Q000187:drug effects; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006454:Hemoglobins; D007958:Leukocyte Count; D008297:Male; D000432:Methanol / Q000031:analogs & derivatives; D008938:Mitosis / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology*; D011763:Pyrrolizidine Alkaloids / Q000494:pharmacology*; D051381:Rats; D012075:Remission, Spontaneous; D012709:Serum Albumin; D012712:Serum Globulins; D013154:Spleen / Q000187:drug effects; D013276:Stomach Ulcer / Q000139:chemically induced; D013950:Thymus Gland / Q000187:drug effects
D001798:Blood Proteins; D006454:Hemoglobins; D011758:Pyrroles; D011763:Pyrrolizidine Alkaloids; D012709:Serum Albumin; D012712:Serum Globulins; D000432:Methanol